DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)

US7232654B1 · kind B1 · utility

Assignees

• INSTITUT PASTEUR · FR
• The United States of America as Represented by the Secretary of the Department of Health and Human Services · US

Inventors

• Jean-Claude Chermann · Marseilles, FR
• Solange Chamaret · Paris, FR
• Claudine Axler-Blin · Paris, FR
• Francoise Rey · Paris, FR
• Marie-Therese Nugeyre · Paris, FR
• Charles Dauguet · Paris, FR
• Willy Rozenbaum · Paris, FR
• Christine Rouzioux · Paris, FR
• Francois Brun-Vezinet · Paris, FR
• Luc Montagnier · Le Plessis-Robinson, FR
• Francoise Barre-Sinoussi · Issy-les-Moulineaux, FR
• Pierre Tiollais · Paris, FR
• Marc Alizon · Paris, FR
• Pierre Sonigo · Paris, FR
• Simon Wain-Hobson · Montigny-le-Bretonneux, FR
• Stewart Cole · Clamart, FR
• Oliver Danos · Fontainebleau, FR
• Robert C. Gallo · Bethesda, US
• Mikulas Popovic · Bethesda, US
• Mangalasseril G. Sarngadharan · Vienna, US
• Jacqueline Gruest · L'Haÿ-les-Roses, FR

Key dates

• Filing date: Sep 19, 1994
• Grant date: Jun 19, 2007
• Expiry date: Sep 19, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q1/703
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

This invention is in the field of lymphadenopathy virus, which has been designated Human Immunodeficiency Virus Type 1 (HIV-1) to detect the presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy syndrome by the use of DNA fragments or the peptides encoded by said DNA fragments. The invention further relates tot he DNA fragments, vectors comprising them and the proteins expressed.